Lluis Puig

Citado por

	Total	Desde 2019
Citas	28611	16942
Índice h	76	59
Índice i10	414	270

3600

1800

900

2700

200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202477 89 105 104 118 125 155 224 214 230 295 309 395 497 920 1290 1608 1822 2082 2287 2630 3175 3589 3564 1573

Acceso público

Ver todo

48 artículos

10 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

MT Fernández-FiguerasAssociate Professor Universitat Internacional de CatalunyaDirección de correo verificada de quironsalud.es
Carle PaulUniversité Toulouse 3 Paul SabatierDirección de correo verificada de chu-toulouse.fr
Giampiero GirolomoniUniversity of VeronaDirección de correo verificada de univr.it
Andrew BlauveltInvestigator, Oregon Medical Research CenterDirección de correo verificada de oregonmedicalresearch.com
Kim Papp and K Papp and K A Papp a...Probity Medical ResearchDirección de correo verificada de probitymedical.com
Christopher E.M. GriffithsProfessor of Dermatology, University of ManchesterDirección de correo verificada de manchester.ac.uk
Peter van de KerkhofradboudDirección de correo verificada de radboudumc.nl
Miquel RiberaDirección de correo verificada de comb.cat
RB WarrenUniversity of manchester UKDirección de correo verificada de manchester.ac.uk
April W. Armstrong, MD MPHProfessor of Dermatology, Associate Dean of Clinical ResearchDirección de correo verificada de post.harvard.edu
Rosa TabernerServicio de Dermatología, Hospital Son Llàtzer (Palma)Dirección de correo verificada de hsll.es
Jorge RomaníMD, PhD, Master Consultant Dermatologist. Hospital General de GranollersDirección de correo verificada de fphag.org
Helena IznardoDermatologist, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de BarcelonaDirección de correo verificada de santpau.cat
Eric SimpsonFrances J. Storrs Medical Dermatology Professor, Dermatology, OHSUDirección de correo verificada de ohsu.edu
Sebastien BARBAROTNantes Université, UMR PhAN, Department of Dermatology, CHU NantesDirección de correo verificada de chu-nantes.fr
Ricardo Ruiz-VillaverdeJefe de Servicio de Dermatologia, Hospital Universitario San Cecilio, GranadaDirección de correo verificada de juntadeandalucia.es
Oriol Yélamos, MD, PhDDermatologist, Researcher, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de BarcelonaDirección de correo verificada de santpau.cat
Claus ZachariaeLedende overlæge, Hud- og allergiafdelingen, Herlev og Gentofte Hospital, Københavns UniversitetDirección de correo verificada de dadlnet.dk
pedro herranzmédico dermatólogoDirección de correo verificada de salud.madrid.org
Ronald VenderAssociate Clinical Professor of Medicine McMaster UniversityDirección de correo verificada de dermatrials.com

Seguir

Lluis Puig

Head, Department of Dermatology, Hospital de la Santa Creu i Sant Pau

Dirección de correo verificada de santpau.cat

dermatology psoriasis atopic dermatitis eczema biologics


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Secukinumab in plaque psoriasis—results of two phase 3 trials RG Langley, BE Elewski, M Lebwohl, K Reich, CEM Griffiths, K Papp, ... New England Journal of Medicine 371 (4), 326-338, 2014	2228	2014
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial IB McInnes, A Kavanaugh, AB Gottlieb, L Puig, P Rahman, C Ritchlin, ... The Lancet 382 (9894), 780-789, 2013	899	2013
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions BB Davidovici, N Sattar, PC Jörg, L Puig, P Emery, JN Barker, ... Journal of Investigative Dermatology 130 (7), 1785-1796, 2010	877	2010
Phase 3 studies comparing brodalumab with ustekinumab in psoriasis M Lebwohl, B Strober, A Menter, K Gordon, J Weglowska, L Puig, K Papp, ... New England Journal of Medicine 373 (14), 1318-1328, 2015	839	2015
Epidemiology of atopic dermatitis in adults: results from an international survey S Barbarot, S Auziere, A Gadkari, G Girolomoni, L Puig, EL Simpson, ... Allergy 73 (6), 1284-1293, 2018	784	2018
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological … C Ritchlin, P Rahman, A Kavanaugh, IB McInnes, L Puig, S Li, Y Wang, ... Annals of the rheumatic diseases 73 (6), 990-999, 2014	720	2014
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and … KB Gordon, B Strober, M Lebwohl, M Augustin, A Blauvelt, Y Poulin, ... The Lancet 392 (10148), 650-661, 2018	604	2018
Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey MG Lebwohl, H Bachelez, J Barker, G Girolomoni, A Kavanaugh, ... Journal of the American Academy of Dermatology 70 (5), 871-881. e30, 2014	573	2014
European consensus statement on phenotypes of pustular psoriasis AA Navarini, AD Burden, F Capon, U Mrowietz, L Puig, S Köks, K Kingo, ... Journal of the European Academy of Dermatology and Venereology 31 (11), 1792 …, 2017	430	2017
Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial RG Langley, TF Tsai, S Flavin, M Song, B Randazzo, Y Wasfi, J Jiang, ... British Journal of Dermatology 178 (1), 114-123, 2018	364	2018
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity CC Zouboulis, T Tzellos, A Kyrgidis, GBE Jemec, FG Bechara, ... British Journal of Dermatology 177 (5), 1401-1409, 2017	345	2017
Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of … A Kavanaugh, C Ritchlin, P Rahman, L Puig, AB Gottlieb, S Li, Y Wang, ... Annals of the rheumatic diseases 73 (6), 1000-1006, 2014	308	2014
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies JMGR de Morales, L Puig, E Daudén, JD Cañete, JL Pablos, AO Martín, ... Autoimmunity reviews 19 (1), 102429, 2020	267	2020
Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin MT Fernandez‐Figueras, C Carrato, X Sáenz, L Puig, E Musulen, ... Journal of the European Academy of Dermatology and Venereology 29 (5), 991-997, 2015	256	2015
The role of IL‐23 and the IL‐23/T_H17 immune axis in the pathogenesis and treatment of psoriasis G Girolomoni, R Strohal, L Puig, H Bachelez, J Barker, WH Boehncke, ... Journal of the European Academy of Dermatology and Venereology 31 (10), 1616 …, 2017	250	2017
Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin‐17 inhibitors and their practical management DM Saunte, U Mrowietz, L Puig, C Zachariae British Journal of Dermatology 177 (1), 47-62, 2017	238	2017
Obesity and psoriasis: body weight and body mass index influence the response to biological treatment L Puig Journal of the European Academy of Dermatology and Venereology 25 (9), 1007-1011, 2011	231	2011
Comparison of biologics and oral treatments for plaque psoriasis: a meta-analysis AW Armstrong, L Puig, A Joshi, M Skup, D Williams, J Li, KA Betts, ... JAMA dermatology 156 (3), 258-269, 2020	227	2020
Clinical and genetic differences between pustular psoriasis subtypes S Twelves, A Mostafa, N Dand, E Burri, K Farkas, R Wilson, HL Cooper, ... Journal of allergy and clinical immunology 143 (3), 1021-1026, 2019	210	2019
PASI 90 response: the new standard in therapeutic efficacy for psoriasis L Puig Journal of the European Academy of Dermatology and Venereology 29 (4), 645-648, 2015	205	2015

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores